Correlation Between Parker Hannifin and Merck

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Parker Hannifin and Merck at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Parker Hannifin and Merck into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Parker Hannifin and Merck Company, you can compare the effects of market volatilities on Parker Hannifin and Merck and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Parker Hannifin with a short position of Merck. Check out your portfolio center. Please also check ongoing floating volatility patterns of Parker Hannifin and Merck.

Diversification Opportunities for Parker Hannifin and Merck

0.58
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Parker and Merck is 0.58. Overlapping area represents the amount of risk that can be diversified away by holding Parker Hannifin and Merck Company in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Merck Company and Parker Hannifin is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Parker Hannifin are associated (or correlated) with Merck. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Merck Company has no effect on the direction of Parker Hannifin i.e., Parker Hannifin and Merck go up and down completely randomly.

Pair Corralation between Parker Hannifin and Merck

Allowing for the 90-day total investment horizon Parker Hannifin is expected to generate 0.87 times more return on investment than Merck. However, Parker Hannifin is 1.15 times less risky than Merck. It trades about 0.1 of its potential returns per unit of risk. Merck Company is currently generating about 0.07 per unit of risk. If you would invest  53,110  in Parker Hannifin on January 29, 2024 and sell it today you would earn a total of  2,254  from holding Parker Hannifin or generate 4.24% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Parker Hannifin  vs.  Merck Company

 Performance 
       Timeline  
Parker Hannifin 

Risk-Adjusted Performance

14 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Parker Hannifin are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. Despite fairly abnormal technical indicators, Parker Hannifin demonstrated solid returns over the last few months and may actually be approaching a breakup point.
Merck Company 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Merck Company are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite quite weak basic indicators, Merck may actually be approaching a critical reversion point that can send shares even higher in May 2024.

Parker Hannifin and Merck Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Parker Hannifin and Merck

The main advantage of trading using opposite Parker Hannifin and Merck positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Parker Hannifin position performs unexpectedly, Merck can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Merck will offset losses from the drop in Merck's long position.
The idea behind Parker Hannifin and Merck Company pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.

Other Complementary Tools

Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Stocks Directory
Find actively traded stocks across global markets
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets